Skip to content

Alifax S.r.l.

Italy IT-MF-000030029 Last updated 21 Oct 2026

Devices
22
Registries
EUDAMEDGUDID
FDA recalls
0

Catalogue22

EUDAMED certificates1

Held under this manufacturer's EUDAMED registration, grouped by notified body; in force first, then by expiry.

EUDAMED certificates (1)

QMD Services GmbH 2962 1 certificate

  • IQMS/00005/0v003 Supplemented

    Quality management system EU IVDR

    Issued
    11 Aug 2026
    Expires
    23 Nov 2030
    Reason
    Add device or group

Notified bodies

About

ATR FTIR & I-DONE: A Rapid, Single-Step Solution for Routine Legionella Identification Date: 5 March 2026 Time: 9:30 AM CET Duration: 10 minutes Language: English Platform: GoToWebinar Alifax INSIDE-OUT Bites is our short-format webinar series delivering focused scientific insights in just 10 minutes: concise, practical, and evidence-based. In this session, Dr. Mandana Mirzajani Sarvandani (University…

From the manufacturer's own website, in their original language. Source

What Alifax S.r.l. makes

Alifax S.r.l. manufactures in vitro diagnostic (IVD) devices for microbiological testing, including the MM GRAM NEG ID for identifying Gram-negative bacteria and the HB&L MRSA KIT for detecting methicillin-resistant *Staphylococcus aureus* (MRSA). These products are designed for laboratory use to support bacterial identification and antibiotic resistance screening.

The company’s portfolio is classified under EU Class C in vitro diagnostic medical devices and is registered in the EU’s eudamed database. Alifax S.r.l. is based in Italy and adheres to EU regulatory requirements for IVD devices.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Alifax S.r.l. manufacture?

Alifax S.r.l. specializes in in vitro diagnostic (IVD) devices used in microbiological testing. Specifically, their portfolio includes products like the MM GRAM NEG ID, which helps identify Gram-negative bacteria, and the HB&L MRSA KIT, designed to detect methicillin-resistant *Staphylococcus aureus* (MRSA). These devices are intended for laboratory environments to aid in bacterial identification and antibiotic resistance screening.

Where is Alifax S.r.l. based, and what regulatory requirements do they follow?

Alifax S.r.l. is based in Italy. Their devices are developed in compliance with EU regulatory standards for in vitro diagnostic medical devices, ensuring they meet the necessary requirements for safety, performance, and quality. This includes adherence to EU IVD classification rules and registration in the EU’s eudamed database.

Which regulatory registries list Alifax S.r.l.’s devices?

Alifax S.r.l.’s in vitro diagnostic devices are listed in the eudamed database, which is the official EU registry for medical devices. This registration confirms their compliance with EU regulatory requirements for IVDs, including classification and traceability.

How are Alifax S.r.l.’s devices classified under EU regulations?

Alifax S.r.l.’s devices fall under EU Class C for in vitro diagnostic medical devices. This classification is determined based on the risk associated with the device’s intended use—Class C includes higher-risk IVDs, such as those used for detecting significant pathogens like MRSA, where accurate results directly impact patient management.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
Italy(from SRN)
Address
30, Via Merano, Nimis, Italy
Phone
+39 0490992000
PRRC contact
Eleonora Marini
EUDAMED SRN
IT-MF-000030029